10/21/2026
PsyRx reports promising ibogaine study results
Preclinical study explores ibogaine and citalopram combination for depression.
Topic archive
psychedelic compounds
4 stories
10/16/2026
Ibogaine shows promise for opioid addiction treatment
Psychedelic ibogaine could offer new hope for opioid addiction recovery.
9/23/2026
NeuroThera expands U.S. patent portfolio with ibogaine
Collaboration with Clearmind Medicine enhances therapeutic potential for mental health and substance use disorders.
8/19/2026
Psyence BioMed supports U.S. push for ibogaine development
U.S. federal actions could accelerate ibogaine's medical potential